Skip to main content
Erschienen in: Supportive Care in Cancer 3/2012

01.03.2012 | Original Article

Falls in persons with chemotherapy-induced peripheral neuropathy

verfasst von: Cindy Tofthagen, Janine Overcash, Kevin Kip

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to evaluate possible risk factors for falls in a group of patients with chemotherapy-induced peripheral neuropathy (CIPN).

Methods

This prospective, descriptive study included persons receiving paclitaxel, docetaxel, oxaliplatin, or cispatin who reported at least one symptom of CIPN. Each patient was invited to complete the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (CIPNAT) and a demographic data questionnaire. Data were analyzed using descriptive statistics and logistic regression.

Results

In this sample (n = 109), fallers (n = 21) had higher doses of chemotherapy(p = 0.045), more neuropathic symptoms (p = 0.016), higher scores on the symptom experience (p = 0.005) and interference items (=0.001) on the CIPNAT, more severe muscle weakness (p < 0.001) and loss of balance (p < 0.001), and higher interference with walking(p < 0.001) and driving (p = 0.022). Patients who received taxanes were more likely to have fallen than patients who received platinum-based chemotherapy (p = 0.022). No significant differences in age or disease stage between fallers and non-fallers were present. Severity of loss of balance and cycle number was independently associated with falling.

Conclusions

This study demonstrates that the risk of falls increases with each cycle of chemotherapy and that patients receiving taxanes may be at greater risk of falls than patients receiving neurotoxic platinum-based drugs. Patients who report muscle weakness and loss of balance or say that their symptoms interfere with walking or driving may be at a higher risk of falls.
Literatur
2.
Zurück zum Zitat Overcash J (2007) Prediction of falls in older adults with cancer: a preliminary study. Oncol Nurs Forum 34(2):341–346PubMedCrossRef Overcash J (2007) Prediction of falls in older adults with cancer: a preliminary study. Oncol Nurs Forum 34(2):341–346PubMedCrossRef
3.
Zurück zum Zitat Holley S (2002) A look at the problem of falls among people with cancer. Clin J Oncol Nurs 6(4):193–197PubMedCrossRef Holley S (2002) A look at the problem of falls among people with cancer. Clin J Oncol Nurs 6(4):193–197PubMedCrossRef
4.
Zurück zum Zitat Joseph EK, Levine JD (2009) Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat. J Pain 10(5):534–541PubMedCrossRef Joseph EK, Levine JD (2009) Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat. J Pain 10(5):534–541PubMedCrossRef
5.
Zurück zum Zitat Lee JJ, Swain SM (2006) Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24(10):1633–1642PubMedCrossRef Lee JJ, Swain SM (2006) Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24(10):1633–1642PubMedCrossRef
6.
Zurück zum Zitat Lipton RB, Apfel SC, Dutcher JP, Rosenberg R, Kaplan J, Berger A, Einzig AI, Wiernik P, Schaumburg HH (1989) Taxol produces a predominantly sensory neuropathy. Neurology 39(3):368–373PubMed Lipton RB, Apfel SC, Dutcher JP, Rosenberg R, Kaplan J, Berger A, Einzig AI, Wiernik P, Schaumburg HH (1989) Taxol produces a predominantly sensory neuropathy. Neurology 39(3):368–373PubMed
7.
Zurück zum Zitat Flatters SJ, Bennett GJ (2006) Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 122(3):245–257PubMedCrossRef Flatters SJ, Bennett GJ (2006) Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 122(3):245–257PubMedCrossRef
8.
Zurück zum Zitat Joseph EK, Chen X, Bogen O, Levine JD (2008) Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 9(5):463–472PubMedCrossRef Joseph EK, Chen X, Bogen O, Levine JD (2008) Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. J Pain 9(5):463–472PubMedCrossRef
9.
Zurück zum Zitat Bove L, Picardo M, Maresca V, Jandolo B, Pace A (2001) A pilot study on the relation between cisplatin neuropathy and vitamin E. J Exp Clin Canc Res 20(2):277–280 Bove L, Picardo M, Maresca V, Jandolo B, Pace A (2001) A pilot study on the relation between cisplatin neuropathy and vitamin E. J Exp Clin Canc Res 20(2):277–280
10.
Zurück zum Zitat Kruse RL, Lemaster JW, Madsen RW (2010) Fall and balance outcomes after an intervention to promote leg strength, balance, and walking in people with diabetic peripheral neuropathy: “feet first” randomized controlled trial. Phys Ther 90:1568–1579PubMedCrossRef Kruse RL, Lemaster JW, Madsen RW (2010) Fall and balance outcomes after an intervention to promote leg strength, balance, and walking in people with diabetic peripheral neuropathy: “feet first” randomized controlled trial. Phys Ther 90:1568–1579PubMedCrossRef
11.
Zurück zum Zitat Son J, Ashton-Miller JA, Richardson JK (2009) Frontal plane ankle proprioceptive thresholds and unipedal balance. Muscle Nerve 39(2):150–157PubMedCrossRef Son J, Ashton-Miller JA, Richardson JK (2009) Frontal plane ankle proprioceptive thresholds and unipedal balance. Muscle Nerve 39(2):150–157PubMedCrossRef
12.
Zurück zum Zitat Richardson JK, Ashton-Miller JA (1996) Peripheral neuropathy: an often-overlooked cause of falls in the elderly. Postgrad Med 99(6):161–172PubMed Richardson JK, Ashton-Miller JA (1996) Peripheral neuropathy: an often-overlooked cause of falls in the elderly. Postgrad Med 99(6):161–172PubMed
13.
Zurück zum Zitat Tilling LM, Darawil K, Britton M (2006) Falls as a complication of diabetes mellitus in older people. J Diab Complications 20(3):158–162CrossRef Tilling LM, Darawil K, Britton M (2006) Falls as a complication of diabetes mellitus in older people. J Diab Complications 20(3):158–162CrossRef
14.
Zurück zum Zitat Herndon JG, Helmick CG, Sattin RW, Stevens JA, DeVito C, Wingo PA (1997) Chronic medical conditions and risk of fall injury events at home in older adults. J Am Geriatr Soc 45(6):739–743PubMed Herndon JG, Helmick CG, Sattin RW, Stevens JA, DeVito C, Wingo PA (1997) Chronic medical conditions and risk of fall injury events at home in older adults. J Am Geriatr Soc 45(6):739–743PubMed
15.
Zurück zum Zitat Pandya N, Bookhart B, Mody SH, Funk Orsini PA, Reardon G (2008) Study of anemia in long-term care (SALT): prevalence of anemia and its relationship with the risk of falls in nursing home residents. Curr Med Res Opin 24(8):2139–2149PubMedCrossRef Pandya N, Bookhart B, Mody SH, Funk Orsini PA, Reardon G (2008) Study of anemia in long-term care (SALT): prevalence of anemia and its relationship with the risk of falls in nursing home residents. Curr Med Res Opin 24(8):2139–2149PubMedCrossRef
16.
Zurück zum Zitat Donald IP, Bulpitt CJ (1999) The prognosis of falls in elderly people living at home. Age Ageing 28(2):121–125PubMedCrossRef Donald IP, Bulpitt CJ (1999) The prognosis of falls in elderly people living at home. Age Ageing 28(2):121–125PubMedCrossRef
17.
Zurück zum Zitat Helbostad JL, Leirfall S, Moe-Nilssen R, Sletvold O (2007) Physical fatigue affects gait characteristics in older persons. J Gerontol A Biol Sci Med Sci 62(9):1010–1015PubMedCrossRef Helbostad JL, Leirfall S, Moe-Nilssen R, Sletvold O (2007) Physical fatigue affects gait characteristics in older persons. J Gerontol A Biol Sci Med Sci 62(9):1010–1015PubMedCrossRef
19.
Zurück zum Zitat Katz S, Downs TD, Cash HR, Grotz RC (1970) Progress in development of the index of ADL. Gerontologist 10(1):20–30PubMedCrossRef Katz S, Downs TD, Cash HR, Grotz RC (1970) Progress in development of the index of ADL. Gerontologist 10(1):20–30PubMedCrossRef
20.
Zurück zum Zitat Feldblum I, German L, Bilenko N, Shahar A, Enten R, Greenberg D, Harman I, Castel H, Shahar DR (2009) Nutritional risk and health care use before and after an acute hospitalization among the elderly. Nutrition 25:415–420PubMedCrossRef Feldblum I, German L, Bilenko N, Shahar A, Enten R, Greenberg D, Harman I, Castel H, Shahar DR (2009) Nutritional risk and health care use before and after an acute hospitalization among the elderly. Nutrition 25:415–420PubMedCrossRef
21.
Zurück zum Zitat Carey EC, Covinsky KE, Lui LY, Eng C, Sands LP, Walter LC (2008) Prediction of mortality in community-living frail elderly people with long-term care needs. J Am Geriatr Soc 56(1):68–75PubMedCrossRef Carey EC, Covinsky KE, Lui LY, Eng C, Sands LP, Walter LC (2008) Prediction of mortality in community-living frail elderly people with long-term care needs. J Am Geriatr Soc 56(1):68–75PubMedCrossRef
22.
Zurück zum Zitat Balducci L (2007) Aging, frailty, and chemotherapy. Cancer Control 14(1):7–12PubMed Balducci L (2007) Aging, frailty, and chemotherapy. Cancer Control 14(1):7–12PubMed
23.
Zurück zum Zitat Podsiadlo D, Richardson S (1991) The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142–148PubMed Podsiadlo D, Richardson S (1991) The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142–148PubMed
24.
Zurück zum Zitat Gale CR, Martyn CN, Cooper C, Sayer AA (2007) Grip strength, body composition, and mortality. Int J Epidemiol 36(1):228–235PubMedCrossRef Gale CR, Martyn CN, Cooper C, Sayer AA (2007) Grip strength, body composition, and mortality. Int J Epidemiol 36(1):228–235PubMedCrossRef
25.
Zurück zum Zitat Wrobel JS, Crews RT, Connolly JE (2009) Clinical factors associated with a conservative gait pattern in older male veterans with diabetes. J Foot Ankle Res 2:11PubMedCrossRef Wrobel JS, Crews RT, Connolly JE (2009) Clinical factors associated with a conservative gait pattern in older male veterans with diabetes. J Foot Ankle Res 2:11PubMedCrossRef
26.
Zurück zum Zitat Paul L, Ellis BM, Leese GP, McFadyen AK, McMurray B (2009) The effect of a cognitive or motor task on gait parameters of diabetic patients, with and without neuropathy. Diabet Med 26(3):234–239PubMedCrossRef Paul L, Ellis BM, Leese GP, McFadyen AK, McMurray B (2009) The effect of a cognitive or motor task on gait parameters of diabetic patients, with and without neuropathy. Diabet Med 26(3):234–239PubMedCrossRef
27.
Zurück zum Zitat Macgilchrist C, Paul L, Ellis BM, Howe TE, Kennon B, Godwin J (2010) Lower-limb risk factors for falls in people with diabetes mellitus. Diabet Med 27(2):162–168PubMedCrossRef Macgilchrist C, Paul L, Ellis BM, Howe TE, Kennon B, Godwin J (2010) Lower-limb risk factors for falls in people with diabetes mellitus. Diabet Med 27(2):162–168PubMedCrossRef
28.
Zurück zum Zitat Hile ES, Fitzgerald GK, Studenski SA (2010) Persistent mobility disability after neurotoxic chemotherapy. Phys Ther 90:1649–1657PubMedCrossRef Hile ES, Fitzgerald GK, Studenski SA (2010) Persistent mobility disability after neurotoxic chemotherapy. Phys Ther 90:1649–1657PubMedCrossRef
29.
Zurück zum Zitat Richardson JK, Sandman D, Vela S (2001) A focused exercise regimen improves clinical measures of balance in patients with peripheral neuropathy. Arch Phys Med Rehabil 82(2):205–209PubMedCrossRef Richardson JK, Sandman D, Vela S (2001) A focused exercise regimen improves clinical measures of balance in patients with peripheral neuropathy. Arch Phys Med Rehabil 82(2):205–209PubMedCrossRef
30.
Zurück zum Zitat Balducci S, Iacobellis G, Parisi L, Di Biase N, Calandriello E, Leonetti F, Fallucca F (2006) Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diab Complications 20(4):216–223CrossRef Balducci S, Iacobellis G, Parisi L, Di Biase N, Calandriello E, Leonetti F, Fallucca F (2006) Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diab Complications 20(4):216–223CrossRef
31.
Zurück zum Zitat Ruhland JL, Shields RK (1997) The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies. Phys Ther 77(10):1026–1039PubMed Ruhland JL, Shields RK (1997) The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies. Phys Ther 77(10):1026–1039PubMed
32.
Zurück zum Zitat Bulat T, Hart-Hughes S, Ahmed S, Quigley P, Palacios P, Werner DC, Foulis P (2007) Effect of a group-based exercise program on balance in elderly. Clin Interv Aging 2(4):655–660PubMed Bulat T, Hart-Hughes S, Ahmed S, Quigley P, Palacios P, Werner DC, Foulis P (2007) Effect of a group-based exercise program on balance in elderly. Clin Interv Aging 2(4):655–660PubMed
33.
Zurück zum Zitat de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16):2938–2947PubMed de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16):2938–2947PubMed
34.
Zurück zum Zitat Hilpert F, Stahle A, Tome O, Burges A, Rossner D, Spathe K, Heilmann V, Richter B, du Bois A (2005) Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy—a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynakologische Onkologoie (AGO) Ovarian Cancer Study Group. Support Care Cancer 13(10):797–805PubMedCrossRef Hilpert F, Stahle A, Tome O, Burges A, Rossner D, Spathe K, Heilmann V, Richter B, du Bois A (2005) Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy—a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynakologische Onkologoie (AGO) Ovarian Cancer Study Group. Support Care Cancer 13(10):797–805PubMedCrossRef
35.
Zurück zum Zitat Hochster HS, Grothey A, Childs BH (2007) Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity. J Clin Oncol 25(25):4028–4029PubMedCrossRef Hochster HS, Grothey A, Childs BH (2007) Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity. J Clin Oncol 25(25):4028–4029PubMedCrossRef
36.
Zurück zum Zitat Bakitas MA (2007) Background noise: the experience of chemotherapy-induced peripheral neuropathy. Nurs Res 56(5):323–331PubMedCrossRef Bakitas MA (2007) Background noise: the experience of chemotherapy-induced peripheral neuropathy. Nurs Res 56(5):323–331PubMedCrossRef
37.
Zurück zum Zitat Tofthagen C (2010) Patient perceptions associated with chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 14(3):E22–E28PubMedCrossRef Tofthagen C (2010) Patient perceptions associated with chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 14(3):E22–E28PubMedCrossRef
38.
Zurück zum Zitat Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C (2007) Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 11(6):901–913PubMedCrossRef Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C (2007) Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 11(6):901–913PubMedCrossRef
39.
Zurück zum Zitat Wampler MA, Hamolsky D, Hamel K, Melisko M, Topp KS (2005) Case report: painful peripheral neuropathy following treatment with docetaxel for breast cancer. Clin J Oncol Nurs 9(2):189–193PubMedCrossRef Wampler MA, Hamolsky D, Hamel K, Melisko M, Topp KS (2005) Case report: painful peripheral neuropathy following treatment with docetaxel for breast cancer. Clin J Oncol Nurs 9(2):189–193PubMedCrossRef
40.
Zurück zum Zitat Tofthagen C, McMillan SC, Kip K (2011) Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool. Cancer Nurs (in press) Tofthagen C, McMillan SC, Kip K (2011) Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool. Cancer Nurs (in press)
41.
Zurück zum Zitat Lehky TJ, Leonard GD, Wilson RH, Grem JL, Floeter MK (2004) Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve 29(3):387–392PubMedCrossRef Lehky TJ, Leonard GD, Wilson RH, Grem JL, Floeter MK (2004) Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve 29(3):387–392PubMedCrossRef
42.
Zurück zum Zitat Badros A, Goloubeva O, Dalal JS, Can I, Thompson J, Rapoport AP, Heyman M, Akpek G, Fenton RG (2007) Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature. Cancer 110:1042–1049PubMedCrossRef Badros A, Goloubeva O, Dalal JS, Can I, Thompson J, Rapoport AP, Heyman M, Akpek G, Fenton RG (2007) Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature. Cancer 110:1042–1049PubMedCrossRef
43.
Zurück zum Zitat Storey DJ, Sakala M, McLean CM, Phillips HA, Dawson LK, Wall LR, Fallon MT, Clive S (2010) Capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy? Ann Oncol 21:1657–1661PubMedCrossRef Storey DJ, Sakala M, McLean CM, Phillips HA, Dawson LK, Wall LR, Fallon MT, Clive S (2010) Capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy? Ann Oncol 21:1657–1661PubMedCrossRef
44.
Zurück zum Zitat Argyriou AA, Polychronopoulos P, Koutras A, Iconomou G, Gourzis P, Assimakopoulos K, Kalofonos HP, Chroni E (2006) Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy? Support Care Cancer 14(3):223–229PubMedCrossRef Argyriou AA, Polychronopoulos P, Koutras A, Iconomou G, Gourzis P, Assimakopoulos K, Kalofonos HP, Chroni E (2006) Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy? Support Care Cancer 14(3):223–229PubMedCrossRef
45.
Zurück zum Zitat Dunlap B, Paice JA (2006) Chemotherapy-induced peripheral neuropathy: a need for standardization in measurement. J Support Oncol 4(8):398–399PubMed Dunlap B, Paice JA (2006) Chemotherapy-induced peripheral neuropathy: a need for standardization in measurement. J Support Oncol 4(8):398–399PubMed
Metadaten
Titel
Falls in persons with chemotherapy-induced peripheral neuropathy
verfasst von
Cindy Tofthagen
Janine Overcash
Kevin Kip
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1127-7

Weitere Artikel der Ausgabe 3/2012

Supportive Care in Cancer 3/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.